Pdf/4.15 MB.pdf

This is a handbook for the PhD program in Cancer Biology and Drug Development at China Medical University. The program is a collaboration between China Medical University and Academia Sinica. The handbook outlines the program's objectives, curriculum, and requirements for graduation. It also provides information on the program's faculty, research groups, and facilities. The program is designed to provide students with a comprehensive education in cancer biology and drug development, and to prepare them for careers in research and development.

Key points include:

The program is a four-year PhD program
Students must complete a minimum of 30 credits of coursework
Students must pass a qualifying exam to become a PhD candidate
Students must complete a dissertation and defend it in front of a committee
The program has a number of research groups, including Therapeutics & Pharmacology, Biotechnology & Bioinformatics, Immunology & Virology, Genetics & Epigenetics, and Tumor Biology
The program has a number of faculty members from both China Medical University and Academia Sinica
* The program provides a number of resources and facilities for students, including laboratories, equipment, and funding for research and travel.

Overall, the handbook provides a comprehensive overview of the PhD program in Cancer Biology and Drug Development at China Medical University, and is intended to help students navigate the program and achieve their academic and research goals.